Search research articles
Contact Us
Filters
Showing results (501-510 of 538) with videos related to
Page
of 54
Sort By:
Leukemia
|
August 17, 2011
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models
D J Morrison, L E Hogan, G Condos, et al.
Neuro-Oncology
|
May 27, 2025
Polyamine acetylation mediates crosstalk between cancer cells and myeloid cells to promote mesenchymal/plurimetabolic states in glioblastoma
Ayush B Rana, Timothy M Horton, Vijay S Thakur, et al.
Leukemia & Lymphoma
|
January 5, 2016
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group
Tamara P Miller, Kelly D Getz, Marko Kavcic, et al.
Leukemia
|
May 10, 2017
JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias
C Delgado-Martin, L K Meyer, B J Huang, et al.
AJR. American Journal of Roentgenology
|
April 23, 2011
National CT colonography trial (ACRIN 6664): comparison of three full-laxative bowel preparations in more than 2500 average-risk patients
Amy K Hara, Mark D Kuo, Meridith Blevins, et al.
Blood Advances
|
September 20, 2021
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency
Monika W Perez, Oscar Sias-Garcia, Alfred Daramola, et al.
Oncotarget
|
August 20, 2016
Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors
Niels E Franke, Gertjan L Kaspers, Yehuda G Assaraf, et al.
Cancers
|
April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
Cohort Profile Update: Survey of Health, Ageing and Retirement in Europe: Biomarker data for age-related health conditions
Martina Boersch-Supan, Axel Boersch-Supan, Karen Andersen-Ranberg, et al.
Blood
|
September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report
Fieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Page
of 54
Search research articles
Search
Showing results (501-510 of 538) with videos related to
Sort By:
Page
of 54
Leukemia
|
August 17, 2011
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models
D J Morrison, L E Hogan, G Condos, et al.
Neuro-Oncology
|
May 27, 2025
Polyamine acetylation mediates crosstalk between cancer cells and myeloid cells to promote mesenchymal/plurimetabolic states in glioblastoma
Ayush B Rana, Timothy M Horton, Vijay S Thakur, et al.
Leukemia & Lymphoma
|
January 5, 2016
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group
Tamara P Miller, Kelly D Getz, Marko Kavcic, et al.
Leukemia
|
May 10, 2017
JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias
C Delgado-Martin, L K Meyer, B J Huang, et al.
AJR. American Journal of Roentgenology
|
April 23, 2011
National CT colonography trial (ACRIN 6664): comparison of three full-laxative bowel preparations in more than 2500 average-risk patients
Amy K Hara, Mark D Kuo, Meridith Blevins, et al.
Blood Advances
|
September 20, 2021
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency
Monika W Perez, Oscar Sias-Garcia, Alfred Daramola, et al.
Oncotarget
|
August 20, 2016
Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors
Niels E Franke, Gertjan L Kaspers, Yehuda G Assaraf, et al.
Cancers
|
April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
Cohort Profile Update: Survey of Health, Ageing and Retirement in Europe: Biomarker data for age-related health conditions
Martina Boersch-Supan, Axel Boersch-Supan, Karen Andersen-Ranberg, et al.
Blood
|
September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report
Fieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Page
of 54